XML 16 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
shares in Millions, $ in Millions
Total
Cumulative effect of changes in accounting principles, net of tax
Number of shares of common stock [Member]
Common stock and additional paid-in capital [Member]
Accumulated deficit [Member]
Accumulated deficit [Member]
Cumulative effect of changes in accounting principles, net of tax
Accumulated other comprehensive loss [Member]
Beginning Balance, Shares at Dec. 31, 2019     591.4        
Balance as of beginning of period at Dec. 31, 2019 $ 9,673 $ (2)   $ 31,531 $ (21,330) $ (2) $ (528)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income for basic and diluted EPS 1,825       1,825    
Other comprehensive income (loss), net of taxes (134)           (134)
Dividends declared on common stock (938)       (938)    
Issuance of common stock in connection with the Company’s equity award programs, Shares     0.9        
Issuance of common stock in connection with the Company’s equity award programs 10     10      
Stock-based compensation expense 52     52      
Tax impact related to employee stock-based compensation expense (68)     (68)      
Repurchases of common stock, Shares     (4.3)        
Repurchases of common stock (933)       (933)    
Ending Balance, Shares at Mar. 31, 2020     588.0        
Balance as of end of period at Mar. 31, 2020 9,485     31,525 (21,378)   (662)
Beginning Balance, Shares at Dec. 31, 2019     591.4        
Balance as of beginning of period at Dec. 31, 2019 9,673 $ (2)   31,531 (21,330) $ (2) (528)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income for basic and diluted EPS 5,649            
Ending Balance, Shares at Sep. 30, 2020     583.5        
Balance as of end of period at Sep. 30, 2020 10,959     31,713 (19,851)   (903)
Beginning Balance, Shares at Mar. 31, 2020     588.0        
Balance as of beginning of period at Mar. 31, 2020 9,485     31,525 (21,378)   (662)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income for basic and diluted EPS 1,803       1,803    
Other comprehensive income (loss), net of taxes (121)           (121)
Issuance of common stock in connection with the Company’s equity award programs, Shares     1.0        
Issuance of common stock in connection with the Company’s equity award programs 65     65      
Stock-based compensation expense 101     101      
Tax impact related to employee stock-based compensation expense (81)     (81)      
Repurchases of common stock, Shares     (2.6)        
Repurchases of common stock (591)       (591)    
Other (2)       (2)    
Ending Balance, Shares at Jun. 30, 2020     586.4        
Balance as of end of period at Jun. 30, 2020 10,659     31,610 (20,168)   (783)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income for basic and diluted EPS 2,021       2,021    
Other comprehensive income (loss), net of taxes (120)           (120)
Dividends declared on common stock (952)       (952)    
Issuance of common stock in connection with the Company’s equity award programs, Shares     0.1        
Issuance of common stock in connection with the Company’s equity award programs 5     5      
Stock-based compensation expense 109     109      
Tax impact related to employee stock-based compensation expense (11)     (11)      
Repurchases of common stock, Shares     (3.0)        
Repurchases of common stock (752)       (752)    
Ending Balance, Shares at Sep. 30, 2020     583.5        
Balance as of end of period at Sep. 30, 2020 $ 10,959     31,713 (19,851)   (903)
Beginning Balance, Shares at Dec. 31, 2020 578.3   578.3        
Balance as of beginning of period at Dec. 31, 2020 $ 9,409     31,802 (21,408)   (985)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income for basic and diluted EPS 1,646       1,646    
Other comprehensive income (loss), net of taxes 152           152
Dividends declared on common stock (1,012)       (1,012)    
Issuance of common stock in connection with the Company’s equity award programs, Shares     0.7        
Issuance of common stock in connection with the Company’s equity award programs 6     6      
Stock-based compensation expense 57     57      
Tax impact related to employee stock-based compensation expense (59)     (59)      
Repurchases of common stock, Shares     (3.7)        
Repurchases of common stock (865)       (865)    
Ending Balance, Shares at Mar. 31, 2021     575.3        
Balance as of end of period at Mar. 31, 2021 $ 9,334     31,806 (21,639)   (833)
Beginning Balance, Shares at Dec. 31, 2020 578.3   578.3        
Balance as of beginning of period at Dec. 31, 2020 $ 9,409     31,802 (21,408)   (985)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income for basic and diluted EPS $ 3,994            
Ending Balance, Shares at Sep. 30, 2021 565.0   565.0        
Balance as of end of period at Sep. 30, 2021 $ 8,217     31,989 (22,964)   (808)
Beginning Balance, Shares at Mar. 31, 2021     575.3        
Balance as of beginning of period at Mar. 31, 2021 9,334     31,806 (21,639)   (833)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income for basic and diluted EPS 464       464    
Other comprehensive income (loss), net of taxes (35)           (35)
Issuance of common stock in connection with the Company’s equity award programs, Shares     0.8        
Issuance of common stock in connection with the Company’s equity award programs 47     47      
Stock-based compensation expense 100     100      
Tax impact related to employee stock-based compensation expense (76)     (76)      
Repurchases of common stock, Shares     (6.5)        
Repurchases of common stock (1,592)       (1,592)    
Other 5       5    
Ending Balance, Shares at Jun. 30, 2021     569.6        
Balance as of end of period at Jun. 30, 2021 8,247     31,877 (22,762)   (868)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income for basic and diluted EPS 1,884       1,884    
Other comprehensive income (loss), net of taxes 60           60
Dividends declared on common stock (1,017)       (1,017)    
Issuance of common stock in connection with the Company’s equity award programs, Shares     0.0        
Issuance of common stock in connection with the Company’s equity award programs 9     9      
Stock-based compensation expense 111     111      
Tax impact related to employee stock-based compensation expense (8)     (8)      
Repurchases of common stock, Shares     (4.6)        
Repurchases of common stock $ (1,069)       (1,069)    
Ending Balance, Shares at Sep. 30, 2021 565.0   565.0        
Balance as of end of period at Sep. 30, 2021 $ 8,217     $ 31,989 $ (22,964)   $ (808)